Sarah Lieber, M.D.

Sarah R. Lieber, M.D., M.S.C.R., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Digestive and Liver Diseases. Her clinical practice emphasizes patient-centered care for individuals with advanced liver disease in need of liver transplantation.

Originally from New Jersey, Dr. Lieber holds a bachelor's degree in philosophy from Harvard University in Cambridge, Massachusetts. She earned her medical degree at the University of Michigan in Ann Arbor, and completed a residency in internal medicine at the Icahn School of Medicine at Mount Sinai in New York. She then received advanced training in gastroenterology and transplant hepatology through fellowships at the University of North Carolina at Chapel Hill. She also holds a master’s degree in clinical research from UNC’s Gillings School of Global Public Health.

With a strong background in advanced liver disease, clinical research, and ethics, and certified by the American Board of Internal Medicine, Dr. Lieber joined the UT Southwestern faculty in 2020.

Her research interests are focused on liver transplantation outcomes, patient reported outcomes, and health behavior intervention design. She serves as an ad hoc reviewer for Liver Transplantation, Hepatology, The American Journal of Bioethics, Pediatric Transplantation, and Clinical Ethics.

Dr. Lieber is a member of the American Association for the Study of Liver Diseases (AASLD), the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, the American Society of Transplantation, and the European Association for the Study of the Liver.

She is the recipient of the 2018 AASLD Innovation Award and the 2019 AASLD Advanced/Transplant Hepatology Award.

Personal Note

Dr. Lieber’s interests outside of medicine include cooking, cycling, traveling, and spending time with her family and dog.

Medical School

University of Michigan Medical School (2013)

Residency

Mount Sinai Medical Center (2016), Internal Medicine

Graduate School

Gillings School of Public Health - University of North Carolina (2019)

Fellowship

University of North Carolina Chapel Hill (2019), Gastroenterology

Fellowship

University of North Carolina Chapel Hill (2020), Transplant Hepatology

• Health Behavior Intervention Adaptation and Implementation
• Liver Transplantation Outcomes
• Patient-reported Outcomes in Advanced Liver Disease and Liver Transplantation
• Survivorship after Liver Transplantation

Featured Publications

Early Survivorship after Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From The Patient and Caregiver Perspective.

Lieber SR, Kim HP, Baldelli L, Nash R, Teal R, Magee G, Desai CS, Loiselle MM, Lee SC, Singal AG, Marrero JA, Barritt AS, Evon DM, Liver Transpl 2021 Sep

What Survivorship Means to Liver Transplant Recipients-Qualitative Groundwork for A Survivorship Conceptual Model.

Lieber SR, Kim HP, Baldelli L, Nash R, Teal R, Magee G, Loiselle MM, Desai CS, Lee SC, Singal AG, Marrero JA, Barritt AS, Evon DM, Liver Transpl 2021 May

What Liver Transplant Recipients Want in a Smartphone Intervention to Enhance Recovery: Prototype for the LiveRight Transplant App.

Lieber SR, Kim HP, Baldelli L, Evon DM, Teal R, Nash R, Magee G, Desai CS, Gerber D, Serrano P, Shah N, Barritt AS, Liver Transpl 2021 04 27 4 584-589

A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Kim HP, Lieber SR, Rogers ME, Moon AM, Loiselle M, Walker J, Assis DN, Safer R, Gomel R, Evon DM, Hepatol Commun 2020 Oct 4 10 1502-1515

Non-adherence and graft failure in adult liver transplant recipients.

Lieber SR, Volk ML, Dig. Dis. Sci. 2013 Mar 58 3 824-34

Monitoring Cardiovascular Risks Factors After Liver Transplantation May Improve Outcomes.

VanWagner LB, Lieber SR, Liver Transpl 2022 Apr

The Practice of Retransplantation for Recurrent Alcohol-associated Liver Disease in the United States Is Uncommon With Acceptable Outcomes.

Cotter TG, Odenwald MA, Lieber SR, Rich NE, Im G, Charlton M, Singal AG, Mitchell MC, Transplant Direct 2022 Mar 8 3 e1297

Systematic review and meta-analysis: incidence of variceal hemorrhage in patients with cirrhosis undergoing transesophageal echocardiography.

Odewole M, Sen A, Okoruwa E, Lieber SR, Cotter TG, Nguyen AD, Mufti A, Singal AG, Rich NE, Aliment Pharmacol Ther 2022 Mar

"Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era.

Cotter TG, Wang J, Lieber SR, Odenwald MA, Rich NE, Marrero JA, Singal AG, Mitchell MC, Aronsohn A, Charlton M, Fung J, Transplant Direct 2021 Jul 7 7 e707

Antiplatelet Medications Are Associated With Bleeding and Decompensation Events Among Patients With Cirrhosis.

Lieber SR, Jiang Y, Moon A, Barritt AS, J Clin Gastroenterol 2021 May

 Featured Books

Individual Rights versus the Public Interest: Outbreak. In The Picture of Health: Medical Ethics and the Movies

Lieber SR (2015). New York, Oxford University Press

• AASLD Advanced/Transplant Hepatology Award
  American Association for the Study of Liver Diseases (2019-2021)
• Alpha Omega Alpha
  Medical Honor Society (2019)
• AASLD Innovation Fund
  American Association for the Study of Liver Diseases (2018-2020)

• American Association for the Study of Liver Diseases
• American College of Gastroenterology
• American Gastroenterology Association
• American Society for Transplantation
• European Association for Study of Liver Disease